跳至主要内容
临床试验/JPRN-UMIN000025773
JPRN-UMIN000025773已完成未知

A randomized controlled trial comparing Vonoprazan, Amoxicillin and Metronidazole triple therapy and Vonoprazan, Amoxicillin and Clarithromycin triple therapy as a first-line eradication of Helicobacter pylori - RCT comparing VAM and VAC HP eradication as first-line

Yokohama City University (Basic research expenditures)0 个研究点目标入组 124 人开始时间: 2017年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Pregnancy or lactation. Past history of allergy for the drugs used in this study. A patient with brain and spinal cord disease. A patient with infectious mononucleosis. Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. Patient who is disqualified for the study by physicians.

研究者

发起方
Yokohama City University (Basic research expenditures)

相似试验